News from the Bench

Discover what’s going on at CST, receive our latest application notes and tips, read our science features, and learn about our products.


Research More. Spend Less.

Spend $650 or more and get 20% off*

(*Offer valid in the US only. Expires June 30, 2017)



Find answers on our FAQs page.


PhosphoSitePlus® Resource

  • Additional protein information
  • Analytical tools


Product Description

The Intermediate Filaments Antibody Sampler Kit provides an economical means to evaluate the presence and status of intermediate filaments. The kit includes enough primary and secondary antibody to perform four Western blot experiments per antibody.

Specificity / Sensitivity

Pan-Keratin (C11) Mouse mAb detects endogenous levels of total keratin 4, 5, 6, 8, 10, 13 and 18 and does not cross-react with other keratins. Plectin-1 (D6A11) Rabbit mAb recognizes endogenous levels of total plectin-1 protein. GFAP (GA5) Mouse mAb detects endogenous levels of total GFAP protein. Desmin Antibody detects endogenous levels of total desmin protein. Vimentin (R28) Antibody detects endogenous levels of total vimentin protein.

Source / Purification

Pan-Keratin (C11) monoclonal antibody is produced by immunizing animals with a cytoskeleton preparation from A431 cells. GFAP (GA5) monoclonal antibody is produced by immunizing animals with native GFAP purified from pig spinal cord. Desmin monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to carboxy terminal residues of human desmin protein, and Plectin-1 (D6A11) monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu2980 of human plectin-1 protein. Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Arg28 of human vimentin. Antibodies are purified by peptide affinity chromatography.

The cytoskeleton consists of three types of cytosolic fibers: microfilaments (actin filaments), intermediate filaments and microtubules. Major types of intermediate filaments are distinguished and expressed in particular cell types: cytokeratins (epithelial cells), glial fibrillary acidic protein, GFAP (glial cells), desmin (skeletal, visceral and certain vascular smooth muscle cells), vimentin (mesenchyme origin) and neurofilaments (neurons). GFAP and vimentin form intermediate filaments in astroglial cells and modulate their motility and shape (1). In particular, vimentin filaments are present at early developmental stages, while GFAP filaments are characteristic of differentiated and mature brain astrocytes. Thus, GFAP is commonly used as a marker for intracranial and intraspinal tumors arising from astrocytes (2). Vimentin is present in sarcomas, but not carcinomas, and its expression is examined in conjunction with that of other markers to distinguish between the two (3).

Desmin is a myogenic marker expressed in early development that forms a network of filaments that extends across the myofibril and surrounds Z discs. The desmin cytoskeleton provides a connection between myofibrils, organelles and the cytoskeleton (4). Desmin knockout mice develop cardiomyopathy as well as skeletal and smooth muscle defects (5). In humans, desmin related myopathies might be caused by mutations in the corresponding desmin gene or in proteins with which desmin interacts, including αB-crystallin and synemin. Disorganized desmin filaments and the accumulation of protein aggregates comprised predominantly of desmin characterize desmin-related myopathies (reviewed in 6,7).

Keratins assemble into filaments, forming heterodimers of an acidic keratin (or type I keratin, keratins 9 to 23) and a basic keratin (or type II keratin, keratins 1 to 8) (8,9). Keratin isoforms demonstrate tissue- and differentiation-specific profiles, which make them useful as biomarkers (8). Mutations in keratin genes are associated with skin disorders, liver and pancreatic diseases, and inflammatory intestinal diseases (10-13).

Plectin is a large, widely expressed protein that crosslinks the intermediate filament and actin cytoskeleton, mechanically stabilizing cells and tissues. Plectin also plays a role in the regulation of actin dynamics and acts as a scaffold for signaling molecules (14). It is important in the stabilization of hemidesmosomes, crosslinking them to the intermediate filament network. Plectin has been shown to be involved in several signaling cascades. It signals to PKC by binding to and sequestering RACK1, the receptor for activated C kinase 1 (15,16). Plectin is also involved in the regulation of cytokeratin architecture and cell stress response (16), signaling through the chemokine receptor CXCR4 (17), regulation of AMP-activated protein kinase (AMPK) activity and signaling in mouse myotubes (18).

1.  Eng, L.F. et al. (2000) Neurochem Res 25, 1439-51.

2.  Moll, R. et al. (1982) Cell 31, 11-24.

3.  Goebel, H.H. et al. (1987) Acta Histochem Suppl 34, 81-93.

4.  Chang, L. and Goldman, R.D. (2004) Nat Rev Mol Cell Biol 5, 601-13.

5.  Leader, M. et al. (1987) Histopathology 11, 63-72.

6.  Ramaekers, F.C. and Bosman, F.T. (2004) J Pathol 204, 351-4.

7.  Capetanaki, Y. et al. (2007) Exp Cell Res 313, 2063-76.

8.  Lane, E.B. and McLean, W.H. (2004) J Pathol 204, 355-66.

9.  Li, Z. et al. (1996) Dev Biol 175, 362-6.

10.  Zatloukal, K. et al. (2004) J Pathol 204, 367-76.

11.  Paulin, D. and Li, Z. (2004) Exp Cell Res 301, 1-7.

12.  Owens, D.W. and Lane, E.B. (2004) J Pathol 204, 377-85.

13.  Paulin, D. et al. (2004) J Pathol 204, 418-27.

14.  Wiche, G. (1998) J Cell Sci 111 ( Pt 17), 2477-86.

15.  Osmanagic-Myers, S. and Wiche, G. (2004) J Biol Chem 279, 18701-10.

16.  Osmanagic-Myers, S. et al. (2006) J Cell Biol 174, 557-68.

17.  Ding, Y. et al. (2008) Exp Cell Res 314, 590-602.

18.  Gregor, M. et al. (2006) J Cell Sci 119, 1864-75.

For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Intermediate Filaments Antibody Sampler Kit